These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31478151)
41. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry. Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634 [TBL] [Abstract][Full Text] [Related]
42. Case report: Physical therapy management of axial dystonia. Voos MC; Oliveira Tde P; Piemonte ME; Barbosa ER Physiother Theory Pract; 2014 Jan; 30(1):56-61. PubMed ID: 23848574 [TBL] [Abstract][Full Text] [Related]
43. Headache attributed to craniocervical dystonia: A prospective cohort study. Eugenio Ramalho Bezerra M; Sampaio Rocha-Filho PA Eur J Pain; 2020 Sep; 24(8):1484-1494. PubMed ID: 32422691 [TBL] [Abstract][Full Text] [Related]
44. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study. Laubis-Herrmann U; Fries K; Topka H Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435 [TBL] [Abstract][Full Text] [Related]
45. Effective botulinum toxin injection guide for treatment of cervical dystonia. Yi KH; Choi YJ; Cong L; Lee KL; Hu KS; Kim HJ Clin Anat; 2020 Mar; 33(2):192-198. PubMed ID: 31301235 [TBL] [Abstract][Full Text] [Related]
46. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US. Hull M; Anupindi VR; DeKoven M; He J; Bouchard J Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904 [TBL] [Abstract][Full Text] [Related]
47. Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia. Brashear A; Hogan P; Wooten-Watts M; Marchetti A; Magar R; Martin J Adv Ther; 2005; 22(1):49-55. PubMed ID: 15943222 [TBL] [Abstract][Full Text] [Related]
48. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial. van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591 [TBL] [Abstract][Full Text] [Related]
49. Botulinum toxin type A and cervical dystonia: a seven-year follow-up. Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174 [TBL] [Abstract][Full Text] [Related]
50. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule. Oshima M; Deitiker P; Jankovic J; Atassi MZ Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721 [TBL] [Abstract][Full Text] [Related]
51. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin. Marciniec M; Szczepańska-Szerej A; Rejdak K Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754 [TBL] [Abstract][Full Text] [Related]
52. Effect of Neck Botulinum Neurotoxin Injection on Proprioception and Somatosensory-Motor Cortical Processing in Cervical Dystonia. Khosravani S; Buchanan J; Johnson MD; Konczak J Neurorehabil Neural Repair; 2020 Apr; 34(4):309-320. PubMed ID: 32102606 [No Abstract] [Full Text] [Related]
53. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review. Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240 [TBL] [Abstract][Full Text] [Related]
54. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239 [TBL] [Abstract][Full Text] [Related]
55. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. Kessler KR; Skutta M; Benecke R J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694 [TBL] [Abstract][Full Text] [Related]
56. The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia. Hefter H; Samadzazeh S; Rosenthal D J Neurol; 2021 Jan; 268(1):206-213. PubMed ID: 32761340 [TBL] [Abstract][Full Text] [Related]
57. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia. Figgitt DP; Noble S Drugs; 2002; 62(4):705-22. PubMed ID: 11893235 [TBL] [Abstract][Full Text] [Related]
58. [Treatment of focal dystonia with botulinum toxin A]. Sojer M; Wissel J; Müller J; Poewe W Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045 [TBL] [Abstract][Full Text] [Related]
59. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features. Yoshida K Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420 [TBL] [Abstract][Full Text] [Related]
60. Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia? Kreisler A; Djelad S; Simonin C; Baille G; Mutez E; Degardin A; Defebvre L; Labreuche J; Cailliau E; Duhamel A Rev Neurol (Paris); 2022 Jun; 178(6):591-602. PubMed ID: 34916042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]